Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2004.039701v1, 2004; 10.1373/clinchem.2004.039701
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.039701v1
50/12/2353    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexeev, V. L.
Right arrow Articles by Asher, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexeev, V. L.
Right arrow Articles by Asher, S. A.

Received on July 14, 2004
Accepted on September 1, 2004

Automation and Analytical Techniques

Photonic Crystal Glucose-Sensing Material for Noninvasive Monitoring of Glucose in Tear Fluid

Vladimir L. Alexeev 1, Sasmita Das 2, David N. Finegold 3, Sanford A. Asher 2

1 Department of Chemistry, Chevron Science Center, and Glucose Sensing Technologies LLC, Pittsburgh, PA
2 Department of Chemistry, Chevron Science Center
3 Department of Pediatrics, University of Pittsburgh Medical School, University of Pittsburgh, Pittsburgh, PA

Background: We recently developed photonic crystal glucose-sensing material (Alexeev et al., Anal Chem 2003;75:2316-23), which consists of a crystalline colloidal array embedded within a polymer network of a polyacrylamide-poly(ethylene glycol) hydrogel with pendent phenylboronic acid groups. The aim of the present work was to improve this approach for application to noninvasive or minimally invasive monitoring of glucose.

Methods: We used new boronic acid derivatives such as 4-amino-3-fluorophenylboronic acid and 4-carboxy-3-fluorophenylboronic acid as the molecular recognition elements to achieve sensing at physiologic pH values.

Results: The improved photonic glucose-sensing material sensed glucose in the range of the 100 µmol/L concentrations found in tear fluid. The detection limits were ~1 µmol/L in synthetic tear fluid. The visually evident diffraction color shifted across the entire visible spectral region from red to blue over the physiologically relevant tear-fluid glucose concentrations. This sensing material is selective for glucose over galactose, mannose, and fructose.

Conclusions: These new glucose sensors have properties appropriate for use in such glucose-sensing applications as ocular inserts or diagnostic contact lenses for patients with diabetes mellitus.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
G. J. Worsley, G. A. Tourniaire, K. E. S. Medlock, F. K. Sartain, H. E. Harmer, M. Thatcher, A. M. Horgan, and J. Pritchard
Continuous Blood Glucose Monitoring with a Thin-Film Optical Sensor
Clin. Chem., October 1, 2007; 53(10): 1820 - 1826.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. T. Baca, C. R. Taormina, E. Feingold, D. N. Finegold, J. J. Grabowski, and S. A. Asher
Mass Spectral Determination of Fasting Tear Glucose Concentrations in Nondiabetic Volunteers
Clin. Chem., July 1, 2007; 53(7): 1370 - 1372.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the American Association for Clinical Chemistry.